Scientific Program Analyst 1 - 5
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Points of contact
-
- Christine Frate christine.frate@nih.gov (301) 443-3846
- Larhonda Robinson larhonda.robinson@nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services National Institutes of Health is procuring Scientific Program Analyst 1 through 5 services under new requirement task order SOAR-NCI-211640, with an estimated solicitation release date of May 1, 2026 and an estimated award date of June 1, 2026. The services support the National Cancer Institute's ComboMATCH precision medicine program by providing specimen tracking and precise patient data entry for the Designated Laboratory Network, which refers patients with advanced cancer to ComboMATCH for clinical trial matching based on tumor genomic profiles. Requirements include proper specimen handling, laboratory compliance with biosafety protocols, and compliance with federal data protection and biosafety standards that safeguard patient confidentiality and sensitive biological materials and data.
The estimated award value range is $250,000 to $700,000 under NAICS 541690 (Other Scientific and Technical Consulting Services), with no set-aside used. The period of performance runs September 13, 2026 through September 12, 2027. Points of contact are Christine Frate, Contracting Officer (christine.frate@nih.gov, +1 301-443-3846), and Larhonda Robinson (larhonda.robinson@nih.gov).
Forecast text
SOAR-NCI- 211640-Scientific Program Analyst 1 - 5
POP: 9/13/2026-9/12/2027
The services outlined in this task order are essential to the delivery of NCI's precision medicine initiatives and to advancing human healthcare outcomes. The Designated Laboratory Network, which refers cancer patients with advanced disease to the ComboMATCH program for access to novel therapies, plays a critical role in matching patients to appropriate clinical trials based on their tumor genomic profiles. The services provided under this task order ensure accurate specimen tracking and precise entry of patient data-both of which directly impact patient safety, treatment selection, and clinical trial outcomes. Proper specimen handling, tracking, and laboratory compliance with biosafety protocols are not ancillary support functions; they are core operational requirements necessary to sustain the integrity of the ComboMATCH program. These services are vital to protecting both patients and laboratory staff, maintaining the scientific validity of research findings, and ensuring the reliability of clinical trial data. In addition, the task order supports compliance with federal data protection and biosafety standards, safeguarding patient confidentiality and preventing unauthorized access, loss, or misuse of sensitive biological materials and associated data.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast